Delivery Order SPE2DB22D1103-SPE2DB24FTNL4

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,024.32 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of March 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,024.32 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has a completion date of May 23, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,795.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 5, 2024. The award is not associated with a set-aside program and is instead an...
This federal contract award, valued at $1,604.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 28, 2023. This contract award is not designated as a set-aside. AmerisourceBergen...
This federal contract award, valued at $1,570.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, to support military healthcare...
This federal contract award, valued at $1,148.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,024.32 Firm Fixed Price delivery order is for HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of October 23, 2023 and was awarded on October 20, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award with award ID SPE2DX15D3020|SPE2DX24FXRST was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,374.13 firm-fixed-price contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. This delivery order contract has an ultimate completion date of August 1, 2024. Amerisourcebergen, the prime contractor, does not have any major subcontractors...
This federal contract award, valued at $1,157.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract is for the delivery of Humalog 100 unit/mL KwikPen 3mL, a prescription insulin medication. There was no...
This federal contract award, valued at $1,388.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTNL4
    Delivery Order

This federal contract award, valued at $1,024.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.

The contract covers the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. There is no set-aside designation for this contract, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for supplying this pharmaceutical product to support military healthcare programs, including those serving military personnel, veterans, and other federal beneficiaries. The contract has an ultimate completion date of July 12, 2024.

Generated 5/17/25, 10:11 AM